Conatus Pharma Could Nearly Quadruple, According To H.C. Wainwright Targets
September 22, 2015 at 12:49 PM EDT
The share price of Conatus Pharmaceuticals, Inc. (NASDAQ: CNAT) has declined 30.77 percent year-to-date. HC ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.